Survival in glioblastoma: a review on the impact of treatment modalities.
about
Advance Care Planning in Glioblastoma PatientsCombination Treatment with the GSK-3 Inhibitor 9-ING-41 and CCNU Cures Orthotopic Chemoresistant Glioblastoma in Patient-Derived Xenograft Models.Diffusible Factors Secreted by Glioblastoma and Medulloblastoma Cells Induce Oxidative Stress in Bystander Neural Stem Progenitors.Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients.Impact of treatment on survival of patients with secondary glioblastoma.On glioblastoma and the search for a cure: where do we stand?Glioblastoma in the elderly: treatment patterns and survival.Long non-coding RNA in glioma: signaling pathways.Cancer stem cells: The potential role of autophagy, proteolysis, and cathepsins in glioblastoma stem cells.Epithelial growth factor receptor expression influences 5-ALA induced glioblastoma fluorescenceOverexpression of mitochondrial serine hydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas.Effects of soluble CPE on glioma cell migration are associated with mTOR activation and enhanced glucose flux.The transcription factor ATF5: role in cellular differentiation, stress responses, and cancer.A 4-miRNA signature to predict survival in glioblastomas.Melatonin attenuates hypoxia-induced epithelial-mesenchymal transition and cell aggressive via Smad7/ CCL20 in glioma.Vaccination in the immunotherapy of glioblastoma.Synergistic interaction of the cannabinoid and death receptor systems - a potential target for future cancer therapies?Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.From imaging to biology of glioblastoma: new clinical oncology perspectives to the problem of local recurrence.Characterization of active and infiltrative tumorous subregions from normal tissue in brain gliomas using multiparametric MRI.Knockdown of long non-coding RNA ANRIL inhibits proliferation, migration, and invasion but promotes apoptosis of human glioma cells by upregulation of miR-34a.Comparative proteomics as a tool for identifying specific alterations within interferon response pathways in human glioblastoma multiforme cells.Prognostic Molecular and Imaging Biomarkers in Primary Glioblastoma.Combinatorial effects of VEGFR kinase inhibitor axitinib and oncolytic virotherapy in mouse and human glioblastoma stem-like cell models.Hypoxia activates enhanced invasive potential and endogenous hyaluronic acid production by glioblastoma cells.Long noncoding RNA MALAT1 knockdown reverses chemoresistance to temozolomide via promoting microRNA-101 in glioblastoma.Overexpression of p53 delivered using recombinant NDV induces apoptosis in glioma cells by regulating the apoptotic signaling pathway.CCNG2 Overexpression Mediated by AKT Inhibits Tumor Cell Proliferation in Human Astrocytoma Cells.The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models.Natural Diterpenoid Isoferritin A (IsoA) Inhibits Glioma Cell Growth and Metastasis via Regulating of TGFβ-Induced EMT Signal Pathway.Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models.Bivalent Chromatin Domains in Glioblastoma Reveal a Subtype-Specific Signature of Glioma Stem Cells.Astrocytic Tumors in Mexico: An Overview of Characteristics and Prognosis in an Open Reference Center for Low-Income PopulationGlioblastoma in the setting of prior lower grade gliomas - insights from SEER databaseVerteporfin selectively kills hypoxic glioma cells through iron-binding and increased production of reactive oxygen speciesLong Non-Coding RNAs in Gliomas: From Molecular Pathology to Diagnostic Biomarkers and Therapeutic TargetsNew Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective
P2860
Q28067320-691B7E8C-5343-4539-BE3D-1EE9C8FEC3A3Q33869702-1B704AA2-C5A2-454C-9712-E9A6AA53FFD6Q37174083-77F0A054-39A8-467A-954A-E762EA0B23E9Q37643205-34DA3B4D-FCF8-4252-834E-9568C4D5F649Q38754944-D8D3D075-F4A7-4F50-BA9E-4BE21E81C58DQ38756293-122C7CA3-BDC8-45A4-8EB8-C4FA50C8E758Q39045945-48E5A66C-AA77-42F2-B1A6-93E2AAC15C94Q39130527-BECAB2AB-E864-425A-96EC-73D9473F4D57Q39202839-033362B8-C0A0-403D-8310-A20B8545276FQ41192103-E547967D-55CC-422B-9CF5-6153EBB00E2DQ41200567-6B4DE514-325A-45E1-A852-4D385935E415Q42004283-04941263-2030-4CB8-9F0E-1B6DC9BB8AE1Q46003320-1240E3DF-113D-4203-9747-6D9CF6FD4D22Q47136071-5149CE27-361A-47C1-A468-4603D0618093Q47164243-50BED368-2F7E-4CB0-9064-04AD3125DF4BQ47583155-7FC0ED86-6E02-4581-AEAB-0D6C029D7BFEQ47742909-5874271C-9548-48B3-803F-50DAF2AE4097Q47748770-8C057AAF-D658-476F-B6FE-B38CEDFC7C7AQ47863423-82DD3432-3F9B-4D46-A1F1-B3F0B9830713Q48089392-FBCF9DD5-C851-4266-87E1-28C8E635DEFCQ48149973-6D434C5A-411B-4BBD-8AA6-DB8B7BF74663Q50128059-DB8D6952-1332-463D-82EE-506876E01948Q51138357-17C72D38-C95D-4EDB-A5CB-8FF6BF42A6D6Q52337612-1F4A8E7A-B6C2-4801-B55B-37747030F290Q52372216-5D69F6BD-8F3E-423F-BBF1-FA68BF75C84EQ52685797-38D99EF3-34BE-4DAA-A236-DC2590040B7FQ54219825-AAA97599-F926-4DDD-AEFC-FC19B64A4192Q54979866-DA92A69C-148F-4601-BF13-40D001C0CAD6Q55332403-379E3372-BA52-4ECA-90A8-C7E351DA9EFAQ55361238-80962BB7-6B2A-4670-939C-0F2C20D896A6Q55363919-D354B0AD-483B-4D3C-82C3-E4E46005444CQ55457441-5665A65B-8D1F-42DF-8F81-D3BC37C6C00AQ57057955-FB6BB26D-8052-4504-8ED4-BEE1A249C9E2Q57117142-9D665960-DC5E-4B84-A3A0-3679A6FA1B98Q58698639-080B582B-9C70-490A-AD44-F63A0768F440Q58742548-8B0E9EC9-797B-4D10-8AFA-A8ADE7BACB7AQ58801701-D7673B0D-88C2-44FE-8FAF-707F10438D0F
P2860
Survival in glioblastoma: a review on the impact of treatment modalities.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Survival in glioblastoma: a review on the impact of treatment modalities.
@ast
Survival in glioblastoma: a review on the impact of treatment modalities.
@en
type
label
Survival in glioblastoma: a review on the impact of treatment modalities.
@ast
Survival in glioblastoma: a review on the impact of treatment modalities.
@en
prefLabel
Survival in glioblastoma: a review on the impact of treatment modalities.
@ast
Survival in glioblastoma: a review on the impact of treatment modalities.
@en
P2860
P1476
Survival in glioblastoma: a review on the impact of treatment modalities
@en
P2093
E M Corrales-García
P2860
P2888
P304
P356
10.1007/S12094-016-1497-X
P577
2016-03-10T00:00:00Z